Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Cognition Disorders

• Probiotics in Mild Alzheimer's Disease
• Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
• Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856
• Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
• A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect
• MW151 and HA-WBRT in Patients With Brain Metastases
• The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia
• Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill
• Corticosteroids in Community Acquired Pneumonia
• Effect of Vortioxetine on Cognitive Symptoms in Patients With Schizophrenia
• Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
• Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders in Patients With Ischemic Stroke in the Carotid Arteries
• Assessing Improvement in Cognitive Deficit in CRS in Patients Treated With Medical Vs Surgical Management
• Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
• NeuroCognition After Carotid Recanalization
• Neuroimmune Dysfunction in Alcohol Use Disorder
• Influence of Intrathecal Dexamethasone Administration for Proximal Femoral Fractures
• A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
• Memory and Antioxidants in Vascular Impairment Trial
• A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol
• Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG
• Minocycline for Alcohol Use Disorder
• Deferiprone to Delay Dementia (The 3D Study)
• Putative Cognitive Enhancer VU319
• Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)
• Early Cognitive Function in Elderly Patients After Laser Laryngeal Surgery: Des vs Prop
• The Effect of Retrobulbar Block for Eye Surgery on Brain Oxygenation and Cognitive Functions in Elderly Patients
• IMProving Executive Function Study
• Cognitive Dysfunction in MDD Patients
• Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer
• Lithium As a Treatment to Prevent Impairment of Cognition in Elders
• Appropriate Compatibility of Propofol and Sevoflurane for Orthopaedic Surgery of Patients With MCI
• Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)
• Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients
• To Study the Effect of Sevoflurane and Propofol V Sevoflurane and Dexmedetomidine on Postoperative Cognitive Dysfunction
• Effects of Huperzine A on Presbycusis(Δ,kHz, dB,MMSE, AD)
• Nicotinamide as an Early Alzheimer's Disease Treatment
• Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation
• The Effect of Dexmedetomidine Infusion on Post-operative Cognitive Function and Oxidative Stress in Cardiac Surgery
• Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
• Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers
• A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease
• Vitamin D Supplementation and Neurocognition
• Sodium Butyrate For Improving Cognitive Function In Schizophrenia
• Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease
• The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND
• Genomic Outcomes of Metformin
• Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment
• Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment
• Effect of Methylphenidate on Cancer-related Cognitive Impairment
• Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome
• CAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia
• A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics
• A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)
• Comparison of Postoperative Outcome After Sevoflurane and Propofol Anaesthesia
• Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
• Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium
• Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations
• Donepezil Attenuate Postoperative Cognitive Dysfunction
• Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction
• Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias
• Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
• TAK-071 Scopolamine-Induced Cognitive Impairment Study
• An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)
• Ketamine and Postoperative Cognitive Dysfunction
• A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects
• A Pilot of the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment
• A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)
• 18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
• The Influence of Postoperative Analgesia on Systemic Inflammatory Response and POCD After Femoral Fractures Surgery
• Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
• Comparison of PET Amyloid Imaging in Japanese and Western Subjects
• 11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation
• BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
• The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery
• Implications for Management of PET Amyloid Classification Technology
• The Effects of Anaesthesia on Cerebral Oxygenation and Cognitive Function in Carotid Endarterectomy
• Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants
• A Test of Neural Inertia in Humans With Xenon
• Cognitive Dysfunction Following Cardiac Surgery
• Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia
• Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer
• An fMRI Study of Jianpi Yishen Huatan Granules for Cognitive Impairment After Acute Cerebral Infarction
• Memory Improvement Through Nicotine Dosing (MIND) Study
• Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration
• Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia
• Adderall XR and Cognitive Impairment in MS
• Quality Improvement and Practice Based Research in Neurology Using the EMR
• Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
• Cognitive Functions During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma
• [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease
• A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
• Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD
• Candesartan's Effects on Alzheimer's Disease And Related Biomarkers
• The Study of Jian Pi Yi Shen Hua Tan Granules in Cognitive Impairment After Acute Cerebral Infarction
• A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
• Evaluation of Lithium as a Glycogen-Synthase-Kinase-3 (GSK-3) Inhibitor in Mild Cognitive Impairment
• Phenytoin for Memory Impairment Secondary to Megestrol
• The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects
• Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment
• Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
• Ascending Dose Study of CT1812 in Healthy Volunteers
• [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)
• The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
• The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment
• The Effect of Nimodipine on the Postoperative Cognitive Dysfunction
• Mirabegron in Parkinson Disease and Impaired Cognition
• Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy
• Gulf War Illness Inflammation Reduction Trial
• Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine
• Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
• BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)
• A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)
• International Substudy Enigma2 on Postoperative Cognitive Disorders
• Lacunar Intervention Trial 1 (LACI-1)
• Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart
• Acupuncture Prevents Chemobrain in Breast Cancer Patients
• Target Hemodynamics and Brain Injury During General Anesthesia in the Elderly
• Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD
• A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)
• Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study
• Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
• Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia
• Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
• Investigating the Clinical Consequences of Flutemetamol-PET-scanning
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects
• BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
• A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Pilot
• Ritalin, Memory and Attention in MCI: a Behaviour-EEG Study
• Ramelteon in the Prevention of Post-operative Delirium
• Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
• EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders
• Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
• Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study
• Effect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's Disease
• Long Term Postoperative Cognitive Dysfunction in the Elderly Patients
• An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease
• AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease
• Move for Your Mind - Pilot Trial
• Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury
• An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder
• A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
• NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment
• Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia
• Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in MPS I
• Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
• Effects of Different Doses of Dexmedetomidine on Postoperative Cognitive Dysfunction in Elderly Hypertensive Patients
• Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD
• Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
• Citocoline for Treatment of FXTAS
• Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint
• The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment
• Methylphenidate Treatment of Attention Deficits in Epilepsy
• Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya
• Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
• Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
• Dexamethasone and Postoperative Delirium
• Symptomatic Treatment of Vascular Cognitive Impairment
• Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Abdominal Surgery (Neuprodex)
• A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzhei
• The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy
• PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)
• Ketamine and Changes of the Short Portable Mental Status Questionnaire
• Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
• Cognitive Impairment Related to Atrial Fibrillation Prevention Trial
• Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care
• LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy
• CAndesartan vs LIsinopril Effects on the BRain
• Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.
• Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)
• n-3 PUFA for Vascular Cognitive Aging
• Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)
• Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
• Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset
• Translational Neuroscience Optimization of GlyT1 Inhibitor
• Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects
• Brain Aging and Treatment Response in Geriatric Depression
• Characterizing and Predicting Drug Effects on Cognition
• Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment
• The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia
• Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)
• NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects
• Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil
• Body Temperature in Persons With Tetraplegia When Exposed to Cold
• Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia
• Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI)
• Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease
• Nicotine Treatment of Cognitive Decline in Down Syndrome
• The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
• A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers
• Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)
• Arterial Spin Labeling (ASL) MRI for Cognitive Decline
• Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment
• Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction
• DIetary Supplements, Executive funcTions and Vitamin D (DIET-D)
• Optimization of Desflurane in Elderly Patients
• Mild Cognitive Impairment in Men Following Androgen Deprivation
• A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia
• Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images
• Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
• A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline
• Adderall XR and Processing Speed in Multiple Sclerosis (MS)
• A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
• Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease
• Combination Treatment Study for Memory Impairment and Depression
• A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia
• Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease
• Effects of Brain Beta-Amyloid on Postoperative Cognition
• Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension Phase
• Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients
• Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
• NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease
• Effects of Antimuscarinics on Cognition in Spinal Cord Injury
• Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
• Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI)
• Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
• Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans
• A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment
• Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days
• Effects of Atomoxetine in Mild Cognitive Impairment
• Mild Cognitive Impairment in Parkinson's Disease
• Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
• Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment
• Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment
• A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy
• A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
• Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease
• Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
• Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
• Minocycline in Patients With Alzheimer's Disease
• Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease
• DaTSCAN Imaging in Aging and Neurodegenerative Disease
• Efficacy and Safety Study of Shenwu Capsule
• A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment
• Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
• Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)
• Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline
• Egcg, a dyrk1a Inhibitor as Therapeutic Tool for Reversing Cognitive Deficits in Down Syndrome Individuals.
• 18-Month Study of Memory Effects of Curcumin
• The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia
• Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
• Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
• Add On Treatment for Cognitive Deficits in Schizophrenia
• Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders
• Dexamethasone for the Prevention of Postoperative Cognitive Dysfunction
• Attention & Memory Impairments in Menopausal Women
• Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment
• Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment
• Bevacizumab and Lomustine for Recurrent GBM
• Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
• Non-cancer Pain and Cognitive Impairment: A Disabling Relationship
• Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems
• A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
• The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
• Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy Volunteers
• Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes
• A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease
• The Effect of Nicotine on Arousal, Cognition and Social Cognition in Schizophrenic Patients
• Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery
• Long-term Outcome of General Anesthesia on Dysgnosia
• The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects.
• Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)
• Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
• Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
• Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients
• The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients
• This is a Single Ascending Dose Tolerance Study
• Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
• Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
• Study on Cognitive Disorders of Multiple Sclerosis
• Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment
• Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
• Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia
• Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease
• Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI
• Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)
• Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
• Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
• Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia
• TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia
• Gabapentin Treatment of Cannabis Dependence
• Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702
• Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study
• Donepezil and the Risk of Falls in Seniors With Cognitive Impairment
• A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment
• MemoryXL Effects on Mild Cognitive Impairment Patients
• Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
• A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions
• Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)
• Minocycline for HIV+ Cognitive Impairment in Uganda
• A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I
• Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED)
• Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients
• Pharmacological Management of Delirium
• Cognitive Impairment in Patients With Heart Failure
• Treximet in Acute Migraine Headache: Assessing Cognitive Function
• Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial
• Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions
• Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
• Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
• Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers
• Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
• Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10
• Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar Disorder
• A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia
• Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects
• Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)
• Efficacy Study of Strattera for Treating Attention Disorders in Traumatic Brain Injury (TBI)
• A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
• The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease
• The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism
• RIVastigmine In Vascular cognitivE Impairment
• Metformin in Amnestic Mild Cognitive Impairment
• GABA-glutamate Interactions and Psychosis
• The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial
• Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia
• Memantine and Cognitive Dysfunction in Bipolar Disorder
• Effect of AQW051 in Patients With Memory Impairment
• Modafinil, Sleep, and Cognition in Cocaine Dependence
• A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia
• Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)
• The Zeaxanthin and Visual Function Study
• Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
• The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
• The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment
• Hormone and Information Processing Study
• A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
• Postanesthesia Cognitive Recovery and Neuropsychologic Complications
• MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)
• Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits
• MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)
• An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.
• Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
• Galantamine for Cognitive Deficits in Schizophrenia
• Cognitive Protection - Dexmedetomidine and Cognitive Reserve
• Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency
• Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations
• SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)
• Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment
• Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery
• Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane
• Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment
• Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
• Gastrodin Prevents Cognitive Decline Related to Cardiopulmonary Bypass
• Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia
• The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)
• Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis
• Brain Imaging and Mental Disorders of Aging Intervention
• The Impact of Renin-angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study
• SMART: Somatotrophics, Memory, and Aging Research Trial
• Rosiglitazone Effects on Cognition for Adults in Later Life
• A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
• D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
• A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
• A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
• Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
• An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits
• Methylene Blue for Cognitive Dysfunction in Bipolar Disorder
• Interaction of Cobalamin Status With Nitrous Oxide in Relation to Postoperative Cognitive Changes in the Elderly
• The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia
• Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients
• Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia
• Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
• Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment
• Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia
• Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
• Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline
• The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
• The MIND Study: Modifying the INcidence of Delirium
• Nicotine Treatment of Mild Cognitive Impairment (MCI)
• A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.
• Donepezil HCl & Cognitive Deficits in Autism
• Treatment for Early Memory Loss
• Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.
• A Study of Decreased Mental Function Associated With HIV
• Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients
• A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia
• Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
• A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
• Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
• The Effects of Sex Hormones on Cognition and Mood in Older Adults
• Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)
• Memory Impairment Study (Mild Cognitive Impairment Study)